共 108 条
- [1] Altekruse S.F., Henley S.J., Cucinelli J.E., McGlynn K.A., Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States, Am J Gastroenterol, 109, 4, pp. 542-553, (2014)
- [2] Bray F.J.A., Grey N., Et al., Global cancer transitions according to the human development index (2008–2030): a population-based study, Lancet Oncol, 13, 8, pp. 790-801, (2012)
- [3] Mosadeghi S., Liu B., Bhuket T., Wong R.J., Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the U.S.: an updated analysis of the 2000–2011 surveillance, epidemiology, and end results registry, Hepatol Res, (2015)
- [4] Abdalla E.K., Adam R., Bilchik A.J., Jaeck D., Vauthey J.N., Mahvi D., Improving resectability of hepatic colorectal metastases: expert consensus statement, Ann Surg Oncol, 13, 10, pp. 1271-1280, (2006)
- [5] Adam R.D.V., Pascal G., Et al., Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival, Ann Surg, 240, 4, pp. 644-658, (2004)
- [6] Inarrairaegui M.P.F., Bilbao J.I., Et al., Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma, Eur J Surg Oncol, 38, 7, pp. 594-601, (2012)
- [7] Kopetz S., Chang G.J., Overman M.J., Eng C., Sargent D.J., Larson D.W., Et al., Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy, J Clin Oncol, 27, 22, pp. 3677-3683, (2009)
- [8] Jones R.P., Hamann S., Malik H.Z., Fenwick S.W., Poston G.J., Folprecht G., Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer, Eur J Cancer, 50, 9, pp. 1590-1601, (2014)
- [9] Andreou A., Aloia T.A., Brouquet A., Dickson P.V., Zimmitti G., Maru D.M., Et al., Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy, Ann Surg, 257, 6, pp. 1079-1088, (2013)
- [10] Rees M., Tekkis P.P., Welsh F.K., O'Rourke T., John T.G., Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients, Ann Surg, 247, 1, pp. 125-135, (2008)